Close Menu
Home » Raymond James Downgrades Quidel's Stock

Raymond James Downgrades Quidel's Stock

Dec 14, 2015
|
staff reporter

NEW YORK (GenomeWeb) – Investment bank Raymond James has downgraded shares of Quidel to Market Perform from Outperform, citing a mild flu season.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Unexpected Close

GenomeWeb reports that Veritas Genetics is suspending its US operations.

Sweet Assembly

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Oh, You're Aging Well

Certain plasma proteins could be used to gauge a person's age and whether they are aging well, according to HealthDay News.

Science Papers Describe MicroRNA Targeting Efficiency, Approach for Single-Cell High-Throughput Chemical Screens

In Science this week: approach to measure microRNA targeting efficiency, strategy to conduct high-throughput chemical screens at single-cell resolution, and more.

What's Popular?

In Business News

  1. Veritas Genetics Halts US Operations, Lays Off More Than 30

  2. Roche Ending Partnership With Syapse

  3. Illumina, PacBio Dispute UK Regulator's Finding That Merger Would Weaken Competition

  4. Illumina, ArcherDx Expand Partnership on NGS IVD Tests

  5. BC Platforms Partners With Life & Brain Genomics for Omics Analysis

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.